| PERIOD ENDING | 28-Feb-09 | 30-Nov-08 | 31-Aug-08 | 31-May-08 | | Total Revenue | 307,361 | 919,037 | 681,610 | 639,065 | | Cost of Revenue | 290,958 | 992,602 | 653,732 | 755,840 | | | Gross Profit | 16,403 | (73,565) | 27,878 | (116,775) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 62,035 | 122,285 | 134,296 | 120,178 | | Non Recurring |
-
| 43,400 |
-
| 24,570 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (45,632) | (239,250) | (106,418) | (261,523) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,513 | 2,792 | (3,702) | 9,522 | | Earnings Before Interest And Taxes | (50,920) | (292,984) | (151,745) | (255,330) | | Interest Expense | 8,652 |
-
|
-
|
-
| | Income Before Tax | (59,572) | (292,984) | (151,745) | (255,330) | | Income Tax Expense | (1,500) | 14,300 | (7,000) | 600 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (58,072) | (307,284) | (144,745) | (255,930) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (58,072) | (307,284) | (144,745) | (255,930) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($58,072) | ($307,284) | ($144,745) | ($255,930) |
|
0.45% Nasdaq 
0.20%
Income Statement
